Limited diagnostic utility of serologic testing for neurologic manifestations of systemic disease in the evaluation of suspected multiple sclerosis: A single-center observational study
Authors:
- 5 December 2022
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 69, 104443
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Prevalence of antinuclear antibody in patients with multiple sclerosis: a case-control studyThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021
- “Better explanations” in multiple sclerosis diagnostic workupNeurology, 2019
- Alternative diagnoses in patients referred to specialized centers for suspected MSMultiple Sclerosis and Related Disorders, 2017
- The contemporary spectrum of multiple sclerosis misdiagnosisNeurology, 2016
- Should we systematically test patients with clinically isolated syndrome for auto-antibodies?Multiple Sclerosis Journal, 2015
- Autoantibodies and Sjogren’s Syndrome in Multiple Sclerosis, a ReappraisalPLOS ONE, 2013
- Recommendations for useful serum testing with suspected multiple sclerosisRevue Neurologique, 2013
- Antinuclear and antiphospholipid antibodies in patients with multiple sclerosisLupus, 2011
- Incidental MRI anomalies suggestive of multiple sclerosisNeurology, 2009
- Differential diagnosis of suspected multiple sclerosis: a consensus approachMultiple Sclerosis Journal, 2008